All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

A 77-Year-Old Woman with DLBCL

home / case-based-peer-perspectives / a-77-year-old-woman-with-dlbcl

John M. Burke, MD, of Rocky Mountain Cancer Centers, explains the rationale behind treating an elderly woman with relapsed diffuse large B-cell lymphoma with tafasitamab and lenalidomide after R-CHOP chemotherapy.

Case Overview: 77-Year-Old Woman With DLBCL

EP. 1: Case Overview: 77-Year-Old Woman With DLBCL

John M. Burke, MD
September 25th 2020

Watch

Approaching DLBCL: Risk Assessment and Prognosis

EP. 2: Approaching DLBCL: Risk Assessment and Prognosis

John M. Burke, MD
September 25th 2020

Watch

DLBCL: Cytogenetic Testing and Treatment Initiation

EP. 3: DLBCL: Cytogenetic Testing and Treatment Initiation

John M. Burke, MD
September 25th 2020

Watch

Frontline Treatment Approaches in DLBCL

EP. 4: Frontline Treatment Approaches in DLBCL

John M. Burke, MD
September 25th 2020

Watch

Current Treatment Approaches for R/R DLBCL

EP. 5: Current Treatment Approaches for R/R DLBCL

John M. Burke, MD
September 25th 2020

Watch

Implications for Treating R/R DLBCL With the L-MIND Regimen

EP. 6: Implications for Treating R/R DLBCL With the L-MIND Regimen

John M. Burke, MD
September 25th 2020

Watch

R/R DLBCL: Observations From the Re-MIND Study

EP. 7: R/R DLBCL: Observations From the Re-MIND Study

John M. Burke, MD
September 25th 2020

Watch

R/R DLBCL: Treating With Tafasitamab Plus Lenalidomide

EP. 8: R/R DLBCL: Treating With Tafasitamab Plus Lenalidomide

John M. Burke, MD
September 25th 2020

Watch

Progress Made in Treating R/R DLBCL

EP. 9: Progress Made in Treating R/R DLBCL

John M. Burke, MD
September 25th 2020

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.